• Citer

Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: Long-term results of a European organization for research and treatment of cancer randomized trial comparing doxorubicin, ethoglucid and transurethral resection alone

par Kurth, Karlheinz;Tunn, Ulf;Ay, Reginald;Schröder, Fritz;Pavone-Macaluso, Michele;Debruyne, Frans;Ten Kate, Fiebo J;De Pauw, Marleen;Sylvester, Richard ;Essed, E.;Caubergh, R.V.;Hoekstra, Jildou;De Voogt, Herman;Newling, Don;De Reijke, Theo M.;Mensink, Han;Groen, Jan;Jakse, G.;Leisinger, Hans Jürg;Richards, Brent;Adib, Rafid;Robinson, Mark T.;Denis, Louis;Bouffioux, Christophe;Schulman, Claude ;Carpentier, Paul
Référence The Journal of urology, 158, 2, page (378-384)
Publication Publié, 1997-08

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: Long-term results of a European organization for research and treatment of cancer randomized trial comparing doxorubicin, ethoglucid and transurethral resection alone
Auteur:	Kurth, Karlheinz; Tunn, Ulf; Ay, Reginald; Schröder, Fritz; Pavone-Macaluso, Michele; Debruyne, Frans; Ten Kate, Fiebo J; De Pauw, Marleen; Sylvester, Richard; Essed, E.; Caubergh, R.V.; Hoekstra, Jildou; De Voogt, Herman; Newling, Don; De Reijke, Theo M.; Mensink, Han; Groen, Jan; Jakse, G.; Leisinger, Hans Jürg; Richards, Brent; Adib, Rafid; Robinson, Mark T.; Denis, Louis; Bouffioux, Christophe; Schulman, Claude; Carpentier, Paul
Informations sur la publication:	The Journal of urology, 158, 2, page (378-384)
Statut de publication:	Publié, 1997-08
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Bladder
	Bladder neoplasms
	Carcinoma
	Doxorubicin
	Drug therapy
	Transitional cell
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0022-5347
	info:doi/10.1016/S0022-5347(01)64484-7
	info:scp/0030852901